Translated title of the contribution: Myasthenia gravis. Indications, aims and role of intensive treatment

A. Braschi, A. Scherini, D. Carbonera, A. Mapelli, G. Bellinzona, F. Bobbio Pallavicini, R. Dionigi, A. Gasperi

Research output: Contribution to journalArticle


Some recent views on pathophysiology of myasthenia gravis are presented. The authors explain the typical damage of myasthenia gravis, i.e. the progressively reduced muscular function on the basis of an autoimmune derangement affecting the motor-end plates. The most commonly used types of treatment, both medical (i.e. antiChE, A.C.T.H., steroids and immunodepressant drugs) and surgical (thymectomy) are reviewed. The very important role of intensive care for the treatment either of myasthenia gravis per se or of possible consequences of some drugs (A.C.T.H. steroids) is also stressed. Finally the authors present their results of their experience on 36 patients affected by myasthenia gravis and admitted to I.C.U. once (29 patients) or twice or more (7 patients). They describe some practical problems presented by patients during their stay in I.C.U.

Original languageItalian
Pages (from-to)871-881
Number of pages11
JournalMinerva Anestesiologica
Issue number11
Publication statusPublished - 1979


ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Braschi, A., Scherini, A., Carbonera, D., Mapelli, A., Bellinzona, G., Bobbio Pallavicini, F., Dionigi, R., & Gasperi, A. (1979). MIASTENIA GRAVIS. INDICAZIONI, SCOPI, MODALITA DEL TRATTAMENTO INTENSIVO. Minerva Anestesiologica, 45(11), 871-881.